Actionnariat et activité des initiés pour Embecta Corp. (EMBC): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $5.13 |
| Capitalisation | $304M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-04 | Morris Milton Mayo | S-Sale | 6,293 | $37K |
| 2026-08-12 | Kurdikar Devdatt | P-Purchase | 30,000 | $141K |
| 2026-08-12 | Elguicze Jacob | P-Purchase | 20,000 | $93K |
| 2026-08-12 | Mann Jeffrey Z | P-Purchase | 20,000 | $100K |
| 2026-08-12 | HOMBACH ROBERT J. | P-Purchase | 45,000 | $224K |
| 2026-08-09 | Casner Jean | F-InKind | 1,480 | $7K |
| 2026-06-01 | Roth Anthony M. | A-Award | 30,000 | |
| 2026-02-11 | Anderson Carrie L | A-Award | 22,841 | |
| 2026-02-11 | HOMBACH ROBERT J. | A-Award | 22,841 | |
| 2026-02-11 | Morris Milton Mayo | A-Award | 22,841 |
Bilan (10 ans)
| Année | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Trésorerie | 0 | 0 | 0 | $330.9M | $326.3M | $267.5M | $225.5M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $127.0M | $120.0M | $150.6M | $23.4M | $17.9M | $248.0M | $148.9M |
| Stocks | $101.0M | $102.0M | $118.0M | $122.8M | $152.1M | $171.5M | $178.6M |
| Actifs Courants | $248.0M | $235.0M | $292.0M | $664.7M | $749.1M | $761.0M | $631.4M |
| Immobilisations Corporelles | $457.0M | $462.0M | $451.0M | $301.6M | $323.2M | $290.4M | $257.2M |
| Goodwill | $16.0M | $16.0M | $16.0M | $15.7M | $15.6M | $15.6M | $15.4M |
| Actifs Incorporels | $16.0M | $14.0M | $18.0M | $8.9M | $9.1M | $8.1M | $7.0M |
| Actifs Totaux | $745.0M | $738.0M | $788.0M | $1.09B | $1.21B | $1.29B | $1.09B |
| Dettes Fournisseurs | $47.0M | $50.0M | $54.2M | $41.4M | $53.5M | $91.0M | $74.2M |
| Dette à Court Terme | 0 | 0 | 0 | $9.5M | $9.5M | $9.5M | $9.5M |
| Passifs Courants | $126.0M | $137.0M | $164.0M | $301.0M | $353.5M | $374.0M | $261.5M |
| Dette à Long Terme | 0 | 0 | 0 | $1.60B | $1.59B | $1.57B | $1.39B |
| Passifs Totaux | $126.0M | $166.0M | $194.0M | $1.98B | $2.04B | $2.02B | $1.74B |
| Réserves | 0 | 0 | 0 | -$577.1M | -$541.1M | -$498.6M | -$445.6M |
| Capitaux Propres | $577.0M | $572.0M | $594.0M | -$891.4M | -$821.7M | -$738.3M | -$651.2M |
| Dette Totale | 0 | 0 | $4.1M | $1.64B | $1.64B | $1.61B | $1.43B |
| Dette Nette | 0 | 0 | $4.1M | $1.31B | $1.31B | $1.34B | $1.20B |
| Fonds de Roulement | $122.0M | $98.0M | $128.0M | $363.7M | $395.6M | $387.0M | $369.9M |
Santé financière
| Dette / Capitaux propres | -2.45 |
| Ratio de liquidité | 1.68 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 2.10 |
Rentabilité
| Rentabilité des capitaux propres | -13.98% |
| Rentabilité du capital investi | 17.81% |
| Rentabilité des actifs | 6.92% |
| Marge brute | 59.89% |
| Marge opérationnelle | 24.85% |
| Marge nette | 8.59% |
Entreprises liées: AQST · CDNA · EBS · EVH · MRVI · MYGN · PRME
Explorer le secteur: Healthcare · Medical - Instruments & Supplies
Plus de sections de EMBC: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions